Variant Bio
PrivateLast Round
Series B
Nov 1, 2021
Est. Valuation
$225M
Total Funding Raised
$122.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Variant Bio is a biotechnology company that develops life-saving therapies by studying the genes of people with exceptional health-related traits.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Variant Bio Comparables
Compare Variant Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BenevolentAI | 81% | |
| Verge Labs | 80% | |
| Xaira Therapeutics | 78% | |
Variant Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 1, 2021 | ||||
| Series A | May 28, 2020 | ||||
| Seed | Oct 1, 2018 |
Key People
Founding team and executive leadership
Variant Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SoftBank Investment Advisers | Series B |
| Vulcan Capital | Series B |
| SoftBank Group | Series B |
| Lux Capital | Series B, Seed, Series A |
| Biomatics Capital Partners | Series A |
| Venture Highway | Series B |
| Cercano Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Craig T. Basson appointed Chief Medical Officer and President of R&D.
- Jan 6, 2026
Partnered with Boehringer Ingelheim to discover novel drug targets for kidney disease.
Variant Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Variant Bio's valuation, stock price, and market status.